Connect Sign In
ARUP CEO Andy Theurer, Chief Scientific Officer Tracy George, and BioHive leaders watch a video featuring George after ARUP received the Best of BioHive Community Impact Award on Thursday.
ARUP Laboratories’ contributions in the form of education, advocacy, and innovation earned the company a Best of Beehive Community Impact Award.
The Best of BioHive awards, which were presented to 14 companies or individuals during a Thursday evening gala at The Depot in Salt Lake City, recognized the best in Utah’s life sciences and healthcare ecosystems and capped off the annual BioHive Live Conference. Andy Theurer, ARUP’s CEO, and Tracy I. George, MD, ARUP’s chief scientific officer and president of ARUP’s Innovation Business Unit (IBU), accepted the award.
“At ARUP, we provide testing to patients in all 50 states, and we’re proud to do all of that testing here in Utah,” Theurer said. “Thank you very much for this fantastic award, and a shoutout to all the brilliant people I work with at ARUP.”
ARUP was chosen because, as a nonprofit enterprise of the University of Utah, it provides scientific and educational resources, including courses for continuing education credit, and maintains ARUP Consult®, a free clinicians’ guide to laboratory test selection and interpretation. ARUP and the U are collaborating to build the Advanced Practice Clinical Laboratory Training Center to bolster educational opportunities for students in medical laboratory sciences in Utah and beyond.
“Utah has a strong life sciences community, and ARUP is helping to grow it with returnships for those who have been away from the workplace for a time period,” George said earlier in the day, speaking to a packed auditorium at the BioHive Live Conference in Sandy, Utah. The company also has new internships, outreach programs at high schools and colleges across the state, and clinical fellowships to train the next generation of scientists.
Throughout 2024, ARUP actively advocated for clinical labs. It hosted numerous elected officials, including Utah Governor Spencer Cox and members of the U.S. House Ways and Means Committee, to discuss healthcare innovation and the FDA’s rule regulating laboratory-developed tests (LDTs). ARUP continues to be at the forefront of education and advocacy regarding the rule and has produced webinars, written articles, and created a requirements matrix to benefit the lab industry.
ARUP’s Institute for Research and Innovation in Diagnostic and Precision Medicine™, which is part of the IBU, continues to drive cutting-edge research through the Sherrie Perkins Research and Innovation Collaboration Grant. This grant fosters partnerships within the medical community and supports research that has the potential to impact patient care. The IBU is focused on the future to develop groundbreaking diagnostic and prognostic technologies and innovative tests to fulfill ARUP’s mission of continually improving patient care.
“We are firmly committed to our mission of improving health with innovative and responsive laboratory medicine,” George said. “Our employees, like me, join ARUP because we believe we can make a difference in patients’ lives.”
